Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia

October 1^st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.

Brexpiprazole Warnings: Side Effects of Rexulti

The Visual Illusion of Efficacy in Psychiatric Drug Trials - Mad In America

Rexulti: Package Insert

Rexulti.PDF

The Best and Worst Antipsychotics for Mania - Part 2, 2021-10-25

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overvie

Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. - Abstract - Europe PMC

Rexulti (Brexpiprazole) - PSYCH-MENTAL HEALTH HUB

Rexulti (Brexpiprazole) - PSYCH-MENTAL HEALTH HUB

ex99-01_img005.jpg

REXULTI® (brexpiprazole) Adjunctive Use in Major Depressive Disorder

Rexulti Full Prescribing Information, Dosage & Side Effects

Spotlight on brexpiprazole and its potential in the treatment of schiz

Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. - Abstract - Europe PMC